Progyny Commemorates 10 Years of Redefining Women’s Health and Family Building Care
Rhea-AI Summary
Progyny (NASDAQ:PGNY) marks its 10-year anniversary on April 1, 2026, celebrating growth in women’s health and family building benefits.
The company highlights support for over 470,000 members, more than 600 employers, coverage of 7.2 million lives, and data-driven clinical outcomes improving IVF and menopause access.
Positive
- 470,000 members supported since 2016
- Coverage expanded to 600+ employers
- 7.2 million lives covered globally
- 12% higher pregnancy rates per IVF transfer
- 23% higher live birth rates vs national average
- 41% fewer egg retrievals per live birth
Negative
- None.
News Market Reaction – PGNY
In the Apr 1 session, PGNY declined 0.71%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 06 | Investor conferences | Neutral | +3.9% | Management participation in multiple March investor conferences and webcasts. |
| Feb 26 | Earnings results | Positive | -20.5% | Reported 4Q and FY 2025 revenue growth and profitability metrics. |
| Feb 12 | Earnings date set | Neutral | -2.6% | Announced timing and logistics for upcoming 4Q and FY 2025 report. |
| Jan 12 | Guidance update | Positive | +5.3% | Indicated results expected slightly above prior guidance before JPM conference. |
| Nov 20 | Research publication | Neutral | -2.2% | Released U.S. men’s health research on fertility attitudes and barriers. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows mixed reactions to news, including a sharp selloff on positive earnings and a strong gain on raised expectations, suggesting investor sensitivity around financial updates despite generally constructive fundamentals.
Over the past six months, Progyny has alternated between operational milestones and investor-focused events. A January 2026 update guiding results slightly above prior expectations saw shares rise 5.3%, yet the actual 4Q/FY 2025 earnings release with revenue of $1.2887B coincided with a -20.49% move. Conference participation and research releases produced modest, mixed reactions. Today’s 10‑year milestone fits the pattern of strategic, brand‑building announcements alongside financial disclosures.
Key Terms
ivf medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Throughout 2026, in partnership with members, providers, and employers, Progyny will highlight a decade of innovation, expanded access, and industry-leading outcomes.
NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- Over the past ten years, millions of individuals and families have gained access to life-changing benefits through Progyny, a global leader in women’s health and family building solutions. Progyny today announces that throughout the year, it will honor the collective efforts of its members, employers, providers, and industry partners who have helped shape this decade of progress. The company has redefined what’s possible in the benefits industry by combining clinical expertise, innovation, and a personalized approach to support members at every stage, from preconception through menopause.
“Ten years ago, we set out to transform family building benefit coverage at a time when support was limited and often out of reach,” said Pete Anevski, CEO, Progyny. “Today, we’re helping millions of people access the care and support they need across every stage of their health journey, from building the family of their dreams to navigating life’s biggest transitions; from preconception to pregnancy, parenting, and menopause. This ten-year milestone reflects what’s possible when employers, providers, and advocates come together to solve one of the biggest challenges in healthcare.”
The company will mark the occasion with a series of initiatives throughout the year centered on community and sparking national conversation. One of the cornerstone events will be during National Infertility Awareness Week (April 19–25), when Progyny will partner with RESOLVE: The National Infertility and Family Building Association to light the Empire State Building in orange alongside infertility advocate and celebrity Whitney Port on April 20. Progyny, RESOLVE, leading employers, and industry advocates will also participate in the NASDAQ Closing Bell Ceremony on April 21, raising awareness for the millions of individuals navigating infertility and family building journeys.
Progyny kicked off the anniversary with “Yeah, Baby Day,” an annual event launched on March 25, 2026, to celebrate each person's milestones, highlighting the moments where support can make all the difference.
A Decade of Partnership, Impact, and Innovation
Since entering the market in 2016, Progyny has supported over 470,000 members and expanded from 5 founding employers to more than 600 employers, covering 7.2 million lives. The company has also grown its global benefits solution to serve employees in over 100 countries, while broadening care across preconception, pregnancy, leave and benefits navigation, postpartum care, parenting, and menopause services. This level of exceptional care delivery has led to significant cost savings for employers and members, and a nearly
“It’s one of our most valued benefits because of the meaningful impact it’s had on so many of our employees’ lives,” said Lisa Wywoda, Head of Total Rewards at Unilever. “Over the past ten years, we’ve been able to support employees across the full journey — from early family planning and egg freezing through IVF — in a way that feels seamless and centered around our needs.”
This level of expertise and clinical integration has also enabled Progyny to build one of the largest fertility data sets, showing that the company delivers
“When we found out we had fertility coverage through Progyny, it felt like a whole new door opened for us,” said Erin Antoniak, Progyny member. “Fertility treatment can be incredibly expensive, and having that support allowed us to move forward with the care we needed during a really uncertain time.”
Over the years, Progyny has helped lead the transformation of women’s health and family building benefits by being the first to introduce a fully inclusive definition of infertility, now recognized by ASRM, and first to offer a fully managed benefits solution with integrated clinical oversight, pharmacy support, and rigorous provider inclusion and credentialing standards. With 10 years of groundbreaking work behind it, Progyny is only just getting started. The company plans to continue to invest in new technologies, work with leading providers to advance clinical innovation, and shape national conversations to raise the standard of care across women’s health.
For more information on Progyny’s 10-year anniversary activities, visit 10 years of Progyny.
About Progyny
Progyny (Nasdaq: PGNY) is a global leader in women’s health and family building solutions, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Media:
Alexis Ford
media@progyny.com
Investors:
James Hart
investors@progyny.com
